abstract |
the present invention relates to solid oral dosage forms comprising plasma kallikrein inhibitor, in particular a solid form (form 1) of the compound of formula a. methods of preparing solid oral dosage forms comprising the compound of formula a using form 1 of the compound of formula a are also provided. |